Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): The OCOG ZAMBONEY study

Mark J. Clemons, Brandy Cochrane, Gregory R. Pond, Nadia Califaretti, Stephen K.L. Chia, Rebecca Alexandra Dent, Xinni Song, Andre Robidoux, Sameer Parpia, David Warr, Daniel Rayson, Kathleen I. Pritchard, Mark N. Levine

科研成果: 期刊稿件 › 文章 › 同行评审

43 引用 （Scopus）

指纹

探究 'Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): The OCOG ZAMBONEY study' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science